MAAT PHARMA SACA (MAAT.PA) Stock Balance Sheet
EPA:MAAT • FR0012634822
Current stock price
5.99 EUR
+0.58 (+10.72%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 15.16M | 11.46M | 4.87M | 16.70M | 43.30M | |||
| Cash Equivalents | 9.71M | 8.69M | 19.41M | 18.54M | N/A | |||
| Marketable Securities | 95.00K | 66.00K | 34.00K | 63.00K | N/A | |||
| Receivables | 6.87M | 5.95M | 5.04M | 4.68M | 3.33M | |||
| Inventories | 84.00K | 64.00K | 190.00K | 47.00K | 33.00K | |||
| Other Current Assets | 1.07M | 1.41M | 2.45M | 2.08M | 605.00K | |||
| Total Current Assets | 32.99M | 27.64M | 31.99M | 42.12M | 47.27M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.33M | 8.60M | 9.17M | 966.00K | 1.11M | |||
| Investments And Advances | 376.00K | 200.00K | 200.00K | 300.00K | 100.00K | |||
| Intangibles | 1.84M | 1.77M | 1.34M | 1.20M | 806.00K | |||
| Other Non-Current Assets | 2.00M | N/A | N/A | N/A | 1.00K | |||
| Total Non-Current Assets | 11.56M | 10.86M | 10.94M | 2.60M | 2.15M | |||
| TOTAL ASSETS | 44.55M | 38.50M | 42.93M | 44.73M | 49.42M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.49M | 3.13M | 3.46M | 2.99M | 1.25M | |||
| Accrued Expenses | 1.95M | 2.08M | 1.35M | 1.29M | 727.00K | |||
| Accounts Payable | 11.81M | 8.83M | 6.35M | 4.51M | 2.47M | |||
| Other Current Liabilities | 728.00K | 525.00K | 369.00K | 437.00K | 250.00K | |||
| Total Current Liabilities | 16.98M | 14.56M | 11.52M | 9.22M | 4.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 14.95M | 12.83M | 10.62M | 8.38M | 4.55M | |||
| Other Non-Current Liabilities | 10.83M | 774.00K | 323.00K | 323.00K | 309.00K | |||
| Total Non-Current Liabilities | 25.77M | 13.60M | 10.94M | 8.70M | 4.86M | |||
| TOTAL LIABILITIES | 42.75M | 28.16M | 22.46M | 17.91M | 9.56M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -28.85M | -26.54M | -18.07M | -12.51M | -7.60M | |||
| Additional Paid In Capital | 28.77M | 35.48M | 37.38M | 38.32M | 46.46M | |||
| Common Shares | 1.89M | 1.40M | 1.16M | 994.00K | 988.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 18.85M | 13.98M | 11.62M | 9.94M | 9.88M | |||
| Tangible Book Value per Share | -0.00 | 0.61 | 1.65 | 2.58 | 3.95 | |||
| Total Shareholders' Equity | 1.80M | 10.34M | 20.47M | 26.81M | 39.86M | |||
| TOTAL LIABILITIES AND EQUITY | 44.55M | 38.50M | 42.93M | 44.73M | 49.42M | |||
| Statistics | ||||||||
| Debt/Equity | 8.31 | 1.24 | 0.52 | 0.31 | 0.11 | |||
| Current Ratio | 1.94 | 1.90 | 2.78 | 4.57 | 10.05 | |||
| Return On Assets (ROA) | -69.72% | -75.07% | -45.93% | -30.66% | -18.25% | |||
| Return On Equity (ROE) | -1726.57% | -279.64% | -96.34% | -51.15% | -22.63% | |||
All data in EUR , ROIC based on taxRate of 0.27